Printer Friendly

Invitrogen Launches the ZOOM Proteomics System; Enables 2D Protein Separation in Hours Instead of Days, Facilitates High Throughput Proteomic Research.

Business Editors & Health/Medical Writers


SAN DIEGO--(BW HealthWire)--June 5, 2002

Invitrogen Corp. (Nasdaq:IVGN) announced today the launch of the ZOOM(R) Proteomics System, a set of new research tools for the rapidly growing field of Proteomics.

The ZOOM(R) IPG Runner(TM), ZOOM(R) IPG Strips and NuPAGE(R) ZOOM(R) Gels enable researchers to study proteins faster and easier by performing 2 Dimensional ("2D") protein gel separation in a mini-gel format in just three hours. The ZOOM Proteomics System is designed to make 2D protein analysis so simple and convenient that even laboratories that have never performed 2D separations can get started quickly and get good results right away.

"With the Human Genome sequence nearly complete, Proteomics, the study of proteins, is the next big challenge for life science researchers," said Lyle Turner, chairman and CEO of Invitrogen Corp. "Many scientists have recognized the power of 2D gels for separating and studying proteins, but only large, specialized laboratories have adopted them for regular use. This is because traditional methods are laborious, complicated, and require several days of research time. Our new ZOOM Proteomics System simplifies this method to a three step, three-hour procedure. Now, any laboratory can perform 2D protein gel separation with a minimal investment of time and money."

2D protein gel separation is a well-known technique that has been used since the 1970s. Proteins are first separated in one dimension by their electrical charge and then in a second dimension by their molecular weight, resulting in an array of thousands of individual proteins. To separate in the first dimension, proteins are applied to an IPG (immobilized pH gradient) strip and subjected to high voltage, causing them to separate into discrete bands. To separate in the second dimension, the IPG strips are placed in a gel-type matrix and the proteins are separated by their molecular weight as they move through the gel, a technique called electrophoresis.

"With typical large format 2D gels, the first dimension requires six to nine hours to run, the second dimension requires 18 hours and post-electrophoresis staining steps, to visualize the proteins, require another three hours," remarked Jay Amshey, R&D director for Invitrogen's Separations and Analysis business. "Conventional techniques require a couple of days to get results compared to about 3 hours with our ZOOM(R) Proteomics System." In addition, our system allows researchers to perform up to twelve 2D protein gel separations with a single set up, thereby enabling true, high-throughput Proteomic research."

With the new ZOOM Proteomics System, the first dimension is run in less than two hours using ZOOM IPG strips that are designed to fit into the ZOOM IPG Runner(TM), a bench top electrophoresis apparatus. The second dimension is run in about 40 minutes, using the patented NOVEX NuPAGE(R) ZOOM Gels. Using Invitrogen's rapid staining products, post-electrophoresis steps can be accomplished in just 30 minutes.

"Initial customer reaction to the ZOOM(R) Proteomics System has been extremely positive," said Turner. "This product illustrates Invitrogen's commitment to enhancing life science discovery by making complicated biological procedures faster, easier, and more accessible to all laboratories."

About Invitrogen:

Invitrogen Corp. develops, manufactures and markets research tools in kit form and provides other research products and services to biotechnology and biopharmaceutical researchers and companies worldwide. The company manufactures and markets thousands of products and services that simplify and improve gene cloning, gene expression, and gene analysis techniques for corporate, academic and government entities. The company also engages in technology licensing, research services, large-scale production, and life science technical expertise and support. Founded in 1987, Invitrogen is headquartered in San Diego and has operations in more than 20 countries and distributor relationships in 40 more. The company employs approximately 2,700 people at its worldwide locations. For more information about Invitrogen Corp., please visit the Web site at

Certain statements contained in this press release are considered "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, and it is Invitrogen's intent that such statements be protected by the safe harbor created thereby. Such statements include, but are not limited to, statements relating to: 1) The ZOOM Proteomics System simplifying protein gel separation and/or enabling laboratories to use the technique with minimal time and/or money investment; 2) The ZOOM Proteomics System enabling high-throughput Proteomic research, and; 3) Invitrogen enhancing life science discovery by making procedures more accessible to all laboratories. Such forward-looking statements are subject to a number of risks, uncertainties and other factors that could cause actual results to differ materially from future results expressed or implied by such forward-looking statements. Potential risks and uncertainties include, but are not limited to: a) Customer acceptance and adoption of the ZOOM Proteomics System; b) Customer use of the ZOOM Proteomics System for high-throughput protein analysis; and c) Invitrogen's ability to continue to develop and market products that will satisfy customer needs, as well as other risks and uncertainties detailed from time to time in Invitrogen's Securities and Exchange Commission filings.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Comment:Invitrogen Launches the ZOOM Proteomics System; Enables 2D Protein Separation in Hours Instead of Days, Facilitates High Throughput Proteomic Research.
Publication:Business Wire
Geographic Code:1USA
Date:Jun 5, 2002
Previous Article:Fitch Ratings Affirms Butler Trust 1999-1 & Newport Trust 1999-A.
Next Article:Game Show Network Brings The Popular Word Game Lingo to American Audiences; Chuck Woolery Hosts New U.S. Game That Tests Word Knowledge.

Related Articles
PE Biosystems and Ludwig Institute Announce Strategic Collaboration to Develop Next Generation Proteomics Software.
Gryphon Sciences Grants Nonexclusive Native Chemical Ligation Sublicense to Invitrogen; Technology is Key to New Products for Studying Protein...
The Human Proteome Organization (HUPO) and Environmental Health. (Commentary).
Proteomics: characterizing the cogs in the machinery of life.
Biomedical Applications of Proteomics.
NHLBI Clinical Proteomics Programs.
Advances in Protein Chemistry, Volume 65: Proteome Characterization and Proteomics.
Invitrogen and the Human Proteome Organisation Enter Protein Research Scientific Partnership; Groups Will Further HUPO Scientific Initiatives, Enable...

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters